Literature DB >> 21616769

The importance of body composition and dry weight assessments in patients with chronic kidney disease.

Szilveszter Dolgos1, A Hartmann, J Bollerslev, P Vörös, L Rosivall.   

Abstract

Chronic volume overload is the major cause of hypertension and other cardiovascular morbidity in dialysis patients. One of the most important goals of physicians who take care of patients with chronic renal failure is to obtain near euvolemia or "dry body weight" in order to maintain or normalize blood pressure and prevent further cardiovascular events. In clinical practice, exact estimation of dry weight in hemodialysis patients remains a major challenge. Alterations in body composition, particularly malnutrition, are common in patients receiving long-term hemodialysis and contribute to a high mortality rate. In contrast, obesity - a known risk factor for cardiovascular morbidity and mortality - is prevalent amongst kidney allograft recipients in - long term after renal transplantation. Several technological tools and biochemical markers for estimation of plasma volume and body composition are available for clinical use. Our aim was to highlight the importance of control of body fluid volume and body composition in patients with chronic kidney disease and to describe the different methods available for such measurements.

Entities:  

Mesh:

Year:  2011        PMID: 21616769     DOI: 10.1556/APhysiol.98.2011.2.2

Source DB:  PubMed          Journal:  Acta Physiol Hung        ISSN: 0231-424X


  3 in total

1.  Hemodialysis-Related Amyloidosis in the Tongue.

Authors:  Satoshi Nakamura; Miki Yamada; Yosuke Iijima; Keisuke Sawada; Shunsuke Hino; Takahiro Kaneko; Norio Horie
Journal:  Case Rep Dent       Date:  2022-05-18

2.  Influence of dry weight reduction on anemia in patients undergoing hemodialysis.

Authors:  Yinghui Deng; Hua Liu; Na Lin; Lina Ma; Wenjing Fu
Journal:  J Int Med Res       Date:  2019-09-17       Impact factor: 1.671

3.  Left atrial diameter and albumin with renal outcomes in chronic kidney disease.

Authors:  Szu-Chia Chen; Jer-Ming Chang; Yi-Chun Tsai; Jiun-Chi Huang; Ho-Ming Su; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Int J Med Sci       Date:  2013-03-16       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.